Aspirin and AMD

In December 2012, a study was published showing that individuals who took aspirin were more likely to develop AMD over a 10 year period. However, this study did not show that using aspirin actually caused AMD, and patients are not advised to stop taking aspirin due to the study results.

Click here to read more...

Welcome

Welcome to Bay Area Retina Associates. We are ophthalmologists and retinal surgeons, physicians who specialize in disorders of the inner portion of the eye. Most of our patients have been referred by another physician or an eye care specialist for more specific evaluation.

At Bay Area Retina Associates we are committed to providing quality compassionate retinal health care to you and your family. Our success is measured by the satisfaction of our patients as well as by the doctors who refer patients to our practice. We continually endeavor to keep your faith and trust by speaking openly and honestly with you about your health care and the services we recommend.

News Update:

BARA's Dr. Subhransu Ray presented the major clinical trial results for ocriplasmin at the recent American Academy of Ophthalmology meeting. Ocriplasmin (Jetrea) is a medicine delivered by intravitreal injection for treatment of vitreomacular adhesion.

New FDA approvals

Lucentis (ranibizumab) was recently FDA approved for treatment of diabetic macular edema. Eylea (aflibercept) was approved in early 2012 for treatment of wet age-related macular degeneration, and more recently was FDA approved for treatment of macular edema associated with central retinal vein occlusion.

These new medications may provide a benefit in some patients. Ask your BARA doctor about the choice of medications available if you are being treated for one of these conditions.